Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05069922 · ClinicalTrials.gov registry record · NA

Randomized Trial of Fresh Frozen Plasma Versus Albumin in Acute Burn Resuscitation

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
59
Enrollment target

NCT05069922 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 59 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05069922, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target

Study Summary

The investigators propose a prospective randomized trial to study fresh frozen plasma (FFP) versus albumin to determine the optimal colloid in burn resuscitations. This work addresses both FY20 focus areas, prolonged field care (PFC) and en route care, along with mitigating secondary effects of acute intervention, such as prevention of over resuscitation. Future military conflicts anticipate more extensive burn and blast injuries, and delayed evacuation. Therefore, the direct comparison of colloids used in burn resuscitation is critical to advancing battlefield medicine. Specifically, this work will provide the foundation for the use of freeze-dried plasma (FDP) in burn care by medical responders in PFC and en route care scenarios. The investigators hypothesize that FFP administration, and later FDP, in burn resuscitation is as safe as albumin, and more efficacious, in both reducing the total volume of fluid required in acute burn resuscitation and correcting burn endotheliopathy.

Interventions

  • OTHER Fresh Frozen Plasma

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2022-02-17
Est. Completion 2025-08-31
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT05069922

The ClinicalTrials.gov registry entry for NCT05069922 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Fresh Frozen Plasma is the first listed.

NCT05069922 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05069922 about?

NCT05069922 is a clinical study titled "Randomized Trial of Fresh Frozen Plasma Versus Albumin in Acute Burn Resuscitation". The investigators propose a prospective randomized trial to study fresh frozen plasma (FFP) versus albumin to determine the optimal colloid in burn resuscitations. This work addresses both FY20 focus areas, prolonged field care (PFC) and en route care, along with mitigating secondary effects of acut...

What is the current status of trial NCT05069922?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2022-02-17. Estimated completion is 2025-08-31.

What interventions are being tested in trial NCT05069922?

The interventions under investigation include: Fresh Frozen Plasma (OTHER).

Who is sponsoring clinical trial NCT05069922?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.